Metal-Based Drugs · 1994 · 28 citations · 2 references
PharmacyOncologyToxicologyCarcinogenesisMolecular ToxicologyOrganometallic ChemistryMutagenicity AssessmentToxicity Risk AssessmentCytogenetic AberrationsCytogenetic ScreeningCytogenetic Toxicity AssessmentMechanisms Of CarcinogenicityMicronucleus Frequency AnalysisMutagenic EffectivenessMutagenic Mechanisms
Two diphenylantimony(III) derivatives of dithiophosphorus ligands, i.e. Ph(2)SbS(2)PPh(2) and Ph(2)SbS(2)P(OPr-i)(2), which were previously found to exhibit antitumor properties, have been now investigated for potential mutagenic effects in healthy and Ehrlich ascites tumor-bearing mice. Two short-term tests, i.e. the micronucleus test and the cytogenetic analysis, were used as end-points for mutagenicity. The results are consistent with a mutagenic potential for both organoantimony(III) compounds tested, the effect being higher for the phosphorodithioato derivative.
2
Mutagenicity Testing: A Practical Approach
British Journal of Cancer · 1986 · 305 citations · Full text